Advertisement

Treatment of Affective Disorders

Clinical and Basic Aspects
  • Nobutaka Motohashi
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 363)

Abstract

The neurological separation of affective disorders into unipolar and bipolar was first propounded by Kleist and Leonhard1,2. Their proposal was examined by Angst and Perris3, who demonstrated the difference in the premorbid personality and clinical course in these two entities. First, unipolar depression is more frequent in females than in males. As for bipolar disorder, there is no difference in frequency between males and females. Second, the genetic penetrance is more pronounced in bipolar disorder than in unipolar depression. Third, the premorbid personality of bipolar disorder is syntonic, while that of unipolar depression is asthenic. Lastly, the periodicity is more rapid in bipolar disorder than in unipolar depression. In their follow-up study in 1978, Angst and colleagues4 demonstrated the change of diagnosis. In about 10% of unipolar depression patients, the diagnosis was changed into bipolar disorder. The unipolar patients with three or more episodes were prone to change their diagnosis.

Keywords

Bipolar Disorder Affective Disorder Mood Stabilizer GABAB Receptor Unipolar Depression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kleist, K. (1947) Froteschritte der Psychiatrie. Frankfurt a. M., Kramer.Google Scholar
  2. 2.
    Leonhard, K. (1957) Aufeiling der Endogenen Psychosen, Berlin, Academie Verlag.Google Scholar
  3. 3.
    Angst, J. and Perris, C. (1968) Zur Nosologie endogener Depressionen. Vergleich der Ergebnisse zeier Untersuchungen. Arch. Psychiat. Z. ges. Neurol. 210: 373–386.Google Scholar
  4. 4.
    Angst, J., Felder, W., Frey, R. and Stassen, H.H. (1978) The course of affective disorders. I. Change of diagnosis of monopolar, unipolar, and bipolar illness. Arch. Psychiat. Nervenkr. 226: 57–64.Google Scholar
  5. 5.
    Kukopulos, A., Reginaldi, D., Laddomada, P., Flons, G., Serra, G. and Tondo, L. (1980) Course of the manic-depressive cycle and changes caused by treatments. Pharmacopsychiatry 13: 156–167.Google Scholar
  6. 6.
    Wehr, T. A. and Goodwin, F.K. (1987) Can antidepressants cause mania and worsen the course of affective illness? Am. J. Psychiatry, 144: 1403–1411.Google Scholar
  7. 7.
    Dunner, D.L. and Fieve, R.R. (1974) Clinical factors in lithium carbonate prophylaxis failure. Arch. Gen. Psychiatry 30: 229–233.PubMedCrossRefGoogle Scholar
  8. 8.
    Schou, M. (1989) Lithium prophylaxis: myths and realities. Am. J. Psychiatry,146: 573–576.PubMedGoogle Scholar
  9. 9.
    Motohashi, N., Shioe, K. and Kariya, T. (1992) Mechanisms of action of antidepressants in affective disorders: comparison with lithium. Lithium 3: 7–14.Google Scholar
  10. 10.
    Post, R.M. (1990) Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine. Pharmacopsychiatry, 23: 3–17.PubMedCrossRefGoogle Scholar
  11. 11.
    Lambert, P.-A., Borselli, S., Marcou, G., Bouchardy, M., Cabrol, G. (1971) Action thymo-régulatrice à long terme du Dépamide dans la psychose maniaco-dépressive. Ann. Med. Psychol. 2: 442–448.Google Scholar
  12. 12.
    Semadeni, G.W. (1976) Etude clinique de l’effet normothymique du dipropylacétamide. Acta Psychiat. Belg. 76: 458–466.Google Scholar
  13. 13.
    Puzynski, S. and Klosiewicz, L. (1984) Valproic acid amide in the treatment of affective and schizoaffective disorders. J. Affect. Disord. 6: 115–121.PubMedCrossRefGoogle Scholar
  14. 14.
    Emrich, H.M., v Zerssen, D., Kissling, W., Möller, H.J. and Windorfer, A. (1980) Effect of sodium valproate on mania: the GABA hypothesis of acute mania. Arch. Psychiatr. Nervenkr. 229: 1–16.PubMedCrossRefGoogle Scholar
  15. 15.
    Pope, H.G. Jr., McElroy, S.L., Keck, P.E. and Hudson, J.I. (1991) Valproate in the treatment of acute mania. Arch. Gen. Psychiatry 48: 62–68.PubMedCrossRefGoogle Scholar
  16. 16.
    Freeman, T.W., Clothier, J.L., Pazzaglia, P., Lesem, M.D. and Swann, A.C. (1992) A double-blind comparison of valproate and lithium in the treatment of acute mania. Am. J. Psychiatry 149: 108–111.PubMedGoogle Scholar
  17. 17.
    McElroy, S.L., Keck, P.E.Jr., Pope, H.G. Jr. and Hudson, J.I. (1988) Valproate in the treatment of rapid-cycling bipolar disorder. J. Clin. Psychopharmacol. 8: 275–279.PubMedCrossRefGoogle Scholar
  18. 18.
    Calabrese, J.R. and Delucchi, G.A. (1990) Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorders. Am. J. Psychiatry 147: 431–434.PubMedGoogle Scholar
  19. 19.
    Post, R.M., Uhde, T.W., Putnam, F.W., Ballanger, J.C. and Berrettini, W.H. (1982) Kindling and carbamazepine in affective illness. J. Nerv. Ment. Dis., 170: 717–731.PubMedCrossRefGoogle Scholar
  20. 20.
    Goddard, G.V. (1967) Development of epileptic seizures through brain stimulation at low intensity. Nature 214: 1020–1021.PubMedCrossRefGoogle Scholar
  21. 21.
    Lloyd, K.G. (1983) Role of GAB Aergic systems in the mechanism of action of antiepileptic drugs. Thérapie 38: 355–362.PubMedGoogle Scholar
  22. 22.
    Lloyd, K.G., Morselli, P.L., Bartholini, G. (1987) GAB A and affective disorders. Med. Biol. 65: 159–165.PubMedGoogle Scholar
  23. 23.
    Motohashi, N., Ikawa, K. and Kariya, T. (1989) GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders? Eur. J. Pharmacol. 166: 95–99.Google Scholar
  24. 24.
    Motohashi, N. (1992) GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Prog. Neuro-Psychopharmacol. & Biol. Psychiatry 16: 571–579.Google Scholar
  25. 25.
    Durcan, M.J. and Morgan, P.F. (1990) Prospective role for adenosine and adenosinergic systems in psychiatric disorders. Psychol. Med. 20: 475–486.PubMedCrossRefGoogle Scholar
  26. 26.
    Clark, M. and Post, R.M. (1989) Carbamazepine, but not caffein, is highly selective for adenosine A1 binding sites. Eur. J. Pharmacol. 164: 399–401.PubMedCrossRefGoogle Scholar
  27. 27.
    Motohashi, N., Shioe, K., Mitsushio, H. and Kariya, T. (1992) Effects of mood stabilizers on adenosine systems in rat brain. Jpn. J. Psychiat. Neurol. 46, 559.Google Scholar
  28. 28.
    Nierenberg, AA and White, K. (1990) What next?: a review of pharmacologie strategies for treatment resistant depression. Psychopharmacol. Bull. 26: 429–460.PubMedGoogle Scholar
  29. 29.
    Austin, M.-P. V., Souza, F.G.M. and Goodwin, G.M. (1991) Lithium augmentation in antidepressant-resistant patients. A quantitative analysis. Br. J. Psychiatry 159: 510–514.Google Scholar
  30. 30.
    de Montigny, C., Cournoyer, G., Morissette, R., Langlois, R. and Caille, G. (1983) Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Arch. Gen. Psychiatry 40: 1327–1334.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Nobutaka Motohashi
    • 1
  1. 1.Department of Neurology and PsychiatryHiroshima University School of MedicineHiroshima 734Japan

Personalised recommendations